IRVINE, US: ChromaDex Corp said that it has agreed for an exclusive worldwide license and supply agreement with Suntava Inc for patent-pending Suntava purple corn. ChromaDex plans to develop an extraction process which will be used to produce a highly concentrated anthocyanin ingredient. ChromaDex believes there is a ready market for cost-effective concentrated anthocyanins having application in dietary supplements, sports nutrition, food & beverage and skin care.
“We could not have asked for a more ideal partner than ChromaDex. They have demonstrated both the wherewithal and expertise in commercializing novel ingredient technologies,” said Bill Petrich, CEO, Suntava.
“Anthocyanins are proven to have many health and wellness benefits; however, the high cost of therapeutically effective dose of concentrated anthocyanins has limited consumer interest and awareness,” said Frank Jaksch, CEO and co-founder, ChromaDex.
“Suntava purple corn is a game changer that will give us a huge raw material cost advantage and allow us to produce an ingredient that we can market well below the current prices of other anthocyanin-rich extracts,” added Jaksch.
Suntava purple corn is derived from a proprietary non-GMO purple corn hybrid. Purple corn has a natural deep purple colour due to high anthocyanin content. Anthocyanins are antioxidants, responsible for the purple, violet, blue and red colours in many plants, fruits and vegetables.
© Worldofchemicals News